In this episode, Dina Uzri interviews Harold Smith, founder and CEO of OyaGen, hearing about his journey
from academia to entrepreneurship, the challenges of balancing dual careers, and the development of antiviral therapeutics targeting HIV and Ebola. Harold discusses the challenges and rewards of navigating setbacks in academia, the importance of partnerships in drug discovery, and the expectations of investors in the biotech industry. He shares his experiences with funding, the realities of starting a biotech company, and the significance of mentorship and collaboration. Harold
emphasizes the need for intellectual growth and the balance between stress and personal well-being, while also outlining his future aspirations for his company, OyaGen.
For more about Harold Smith and OyaGen, check out the links below.
OyaGen – HIV drug discovery towards a cure
Hosted by Dina Uzri, PhD, MBA - Technology Development Program Director at UR Ventures,
University of Rochester
